Mettler-Toledo International (NYSE:MTD) Price Target Raised to $1,475.00

Mettler-Toledo International (NYSE:MTD) had its target price raised by Evercore ISI from $1,450.00 to $1,475.00 in a report published on Monday,Benzinga reports. The firm currently has an outperform rating on the medical instruments supplier’s stock.

A number of other equities analysts have also recently weighed in on the stock. Robert W. Baird upped their price objective on shares of Mettler-Toledo International from $1,362.00 to $1,369.00 and gave the company a “neutral” rating in a research report on Monday. Citigroup raised shares of Mettler-Toledo International from a “sell” rating to a “neutral” rating and upped their price objective for the company from $1,200.00 to $1,300.00 in a research report on Wednesday, December 11th. Wolfe Research initiated coverage on shares of Mettler-Toledo International in a research report on Friday, December 13th. They set a “peer perform” rating on the stock. Wells Fargo & Company increased their price target on shares of Mettler-Toledo International from $1,350.00 to $1,400.00 and gave the stock an “equal weight” rating in a research report on Monday. Finally, Stifel Nicolaus reduced their price target on shares of Mettler-Toledo International from $1,550.00 to $1,450.00 and set a “buy” rating on the stock in a research report on Monday, November 11th. One research analyst has rated the stock with a sell rating, six have given a hold rating and three have assigned a buy rating to the company’s stock. According to MarketBeat, the stock currently has a consensus rating of “Hold” and a consensus target price of $1,368.00.

Mettler-Toledo International Price Performance

NYSE:MTD opened at $1,313.20 on Monday. The firm has a 50-day moving average of $1,281.95 and a two-hundred day moving average of $1,341.62. The stock has a market cap of $27.71 billion, a P/E ratio of 32.40, a PEG ratio of 4.80 and a beta of 1.13. Mettler-Toledo International has a 1-year low of $1,133.46 and a 1-year high of $1,546.93.

Mettler-Toledo International (NYSE:MTD) last posted its quarterly earnings data on Thursday, February 13th. The medical instruments supplier reported $12.41 earnings per share for the quarter, beating analysts’ consensus estimates of $11.76 by $0.65. Mettler-Toledo International had a net margin of 22.29% and a negative return on equity of 564.51%. As a group, equities analysts expect that Mettler-Toledo International will post 41.94 earnings per share for the current year.

Insiders Place Their Bets

In other Mettler-Toledo International news, insider Gerry Keller sold 140 shares of the firm’s stock in a transaction dated Tuesday, December 3rd. The shares were sold at an average price of $1,254.09, for a total value of $175,572.60. Following the transaction, the insider now owns 6 shares of the company’s stock, valued at $7,524.54. This trade represents a 95.89 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this link. 1.94% of the stock is currently owned by corporate insiders.

Hedge Funds Weigh In On Mettler-Toledo International

Large investors have recently bought and sold shares of the business. JPMorgan Chase & Co. lifted its holdings in Mettler-Toledo International by 14.7% in the third quarter. JPMorgan Chase & Co. now owns 221,799 shares of the medical instruments supplier’s stock worth $332,634,000 after acquiring an additional 28,478 shares during the last quarter. Quest Partners LLC lifted its holdings in Mettler-Toledo International by 878.1% in the third quarter. Quest Partners LLC now owns 1,027 shares of the medical instruments supplier’s stock worth $1,540,000 after acquiring an additional 922 shares during the last quarter. Allspring Global Investments Holdings LLC lifted its holdings in Mettler-Toledo International by 14.0% in the third quarter. Allspring Global Investments Holdings LLC now owns 1,240 shares of the medical instruments supplier’s stock worth $1,860,000 after acquiring an additional 152 shares during the last quarter. M&T Bank Corp lifted its holdings in Mettler-Toledo International by 14.3% in the third quarter. M&T Bank Corp now owns 4,926 shares of the medical instruments supplier’s stock worth $7,387,000 after acquiring an additional 615 shares during the last quarter. Finally, Nordea Investment Management AB lifted its holdings in Mettler-Toledo International by 29.8% in the fourth quarter. Nordea Investment Management AB now owns 105,823 shares of the medical instruments supplier’s stock worth $129,919,000 after acquiring an additional 24,285 shares during the last quarter. Institutional investors own 95.07% of the company’s stock.

About Mettler-Toledo International

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.